CharlesBSimoneIIMD

Thoracic Cancer

Research Professor and Chief Medical Officer, New York Proton Center Member, Memorial Sloan Kettering Cancer Center

Overview of Dr. Simone

Dr. Charles Simone is a radiation oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 11 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(843) 606-5908

Education & Training

National Capital ConsortiumChief Residency, Radiation Oncology, 2010 - 2011
National Capital ConsortiumResidency, Radiation Oncology, 2007 - 2011
Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

NY State Medical License 2019 - 2026
MD State Medical License 2007 - 2025
PA State Medical License 2011 - 2018
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2010 Jan 01
Completed
Phase 1, Phase 2
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy Start of enrollment: 2010 Sep 01
Completed
Not Applicable
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy Start of enrollment: 2012 Sep 01
Active, not recruiting
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases Start of enrollment: 2011 Jul 01
Active, not recruiting
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer Start of enrollment: 2016 Aug 04
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

2 citations
Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical Trials.
Heng Li, Nina A Mayr, Robert J Griffin, Hualin Zhang, Damodar Pokhrel
International Journal of Radiation Oncology, Biology, Physics. 2024-07-01
2 citations
Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis.
Ryan S Huang, Ronald Chow, Pradnya Chopade, Andrew Mihalache, Asad Hasan
Radiotherapy and Oncology. 2024-05-01
1 citations
Proton pencil beam scanning craniospinal irradiation (CSI) with a single posterior brain beam: Dosimetry and efficiency.
Lei Hu, Anna Zhai, Qing Chen, Vandana Puri, Chin-Cheng Chen
Medical Dosimetry. 2023-11-30

Journal Articles

Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic
Charles Simone II, MD, JAMA Oncology

Authored Content

Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 PandemicAugust 2020
Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United StatesMay 2018

Press Mentions

Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash TherapyOctober 24th, 2022
MARF to Host International Symposium on Malignant MesotheliomaJuly 20th, 2022
Memorial Sloan Kettering Oncologist Named President of Proton Research GroupFebruary 11th, 2021
Join now to see all